XML 30 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Deficit
9 Months Ended
Jul. 05, 2020
Stockholders' Equity Note [Abstract]  
Stockholders' Deficit STOCKHOLDERS’ DEFICIT
Summary of changes in stockholders’ deficit A reconciliation of the beginning and ending amounts of stockholders’ deficit is presented below (in thousands):
QuarterYear-to-date
July 5,
2020
July 7,
2019
July 5,
2020
July 7,
2019
Balance at beginning of period$(876,926) $(592,514) $(737,584) $(591,699) 
Shares issued under stock plans, including tax benefit—  453  3,559  696  
Share-based compensation expense1,747  1,881  7,612  6,589  
Dividends declared—  (10,326) (18,492) (30,967) 
Purchases of treasury stock—  —  (153,550) —  
Net earnings32,555  13,189  51,915  72,376  
Other comprehensive income (loss), net of taxes15,667  6,756  22,453  (226) 
Cumulative-effect from a change in accounting principle —  —  (2,870) (37,330) 
Balance at end of period$(826,957) $(580,561) $(826,957) $(580,561) 
Repurchases of common stock The Company repurchased 1.9 million shares of its common stock in the first quarter of fiscal 2020 at an average price of $81.41 per share for an aggregate cost of $153.5 million. There were no repurchases of common stock in the second or third quarter of fiscal 2020. As of July 5, 2020, this leaves approximately $122.2 million remaining under share repurchase programs authorized by the Board of Directors, consisting of $22.2 million that expires in November 2020 and $100.0 million that expires in November 2021.
Repurchases of common stock included in our condensed consolidated statement of cash flows for fiscal 2020 include $2.0 million related to repurchase transactions traded in the prior year but settled in 2020.
Dividends — During 2020, the Board of Directors declared two cash dividends of $0.40 per common share which were paid on March 17, 2020 and December 20, 2019 to shareholders of record as of the close of business on March 3, 2020 and December 5, 2019, respectively, and totaled $18.5 million. Future dividends are subject to approval by our Board of Directors.